Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Deployable 3D-Printed Vascular Stent with Surface-Catalysed Endogenous Nitric Oxide Generation.Advanced materials (Deerfield Beach, Fla.) · 2026
   Article
2. Absorbing the Absorb experience-don't let the concept fade away.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2019
   Article
3. BRS implantation in long lesions requiring device overlapping: myth or reality?Journal of thoracic disease · 2017
   Review
4. Recommendations for the use of bioresorbable vascular scaffolds in percutaneous coronary interventions : 2017 revision.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2017
   Article
5. Mid-term and long-term safety and efficacy of bioresorbable vascular scaffolds versus metallic everolimus-eluting stents in coronary artery disease: A weighted meta-analysis of seven randomised controlled trials including 5577 patients.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2017
   Article
6. The first generation ABSORB BVS scaffold; to be or not to be?Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2017
   Article
7. First-Generation Bioresorbable Vascular Scaffolds: Disappearing Stents or Disappearing Evidence?Journal of the American College of Cardiology · 2017
   Article

Corrections and comments

• Comment on
  Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.2017
• Comment on
  Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.2017
• Comment on
  Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.2017

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as